- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02376660
Effect of Oats on Lipid Profile
February 25, 2015 updated by: PepsiCo Global R&D
A Randomized Controlled Trial to Evaluate the Efficacy of 3 g of Soluble Fiber From Oats on the Lipid Profile of Men and Women With Elevated Lipid Levels Aged Between 20 and 50 Years
A randomized control trial to assess the effect of oats on lipid profile of mildly hypercholesterolemic subjects.
Subjects consumed 35g of oats twice daily (total of 70g / day) in place of carbohydrates as part of their usual diet.
70 grams of oats provide 3 grams of soluble fiber.
Control group consumed the usual diet.
Subjects followed up for 4 weeks.
In total 3 assessment visits of the subjects planned for the study period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women between 20 and 50 years old
- Total Cholesterol: ≥ 200 mg/dL and < 240mg/dL
- Availability and willingness to follow study protocol
- Stable body weight for previous 3 months (not more than 5% weight change)
Exclusion Criteria:
- Subjects already on lipid lowering drugs
- LDL-c > 190 mg/dL
- Total cholesterol <200 mg/dL and >240 mg/dL
- Subjects with serum creatinine levels > 1.3 mg/dL (female) or 1.4 mg/dL (male), nephropathy, evidence of hepatic disease or history of alcohol abuse
- Baseline Triglycerides: > 300 mg/dL
- Diabetes (Type 1 or Type 2) as diagnosed by a physician
- Uncontrolled hyperthyroidism (as per physician's discretion)
- Uncontrolled hypertension (as per physician's discretion)
- Acute infections or chronic debilitating diseases like tuberculosis, malignancy, HIV infection etc. Any life threatening serious disorder of the liver, kidneys, heart, lungs or other organs by history
- Irritable bowel syndrome by history
- Unwillingness to give written informed consent for participation in the study.
- Pregnancy & lactation (by history)
- Severe end organ damage
- Subjects with allergy to oats
- Heavy smokers (smoking more than 5 cigarettes per day)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Oats
70 grams oats
|
|
|
Placebo Comparator: usual diet and exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
reduction of total cholesterol
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Blood pressure
Time Frame: 4 weeks
|
4 weeks
|
|
Triglycerides
Time Frame: 4 weeks
|
4 weeks
|
|
LDL-c
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anoop Misra, MD, MBBS, Fortis Clinical Research Limited
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
February 25, 2015
First Submitted That Met QC Criteria
February 25, 2015
First Posted (Estimate)
March 3, 2015
Study Record Updates
Last Update Posted (Estimate)
March 3, 2015
Last Update Submitted That Met QC Criteria
February 25, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- PEP-1205
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mildly Hypercholesterolemic Subjects
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsFrance
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsCanada
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsUnited Kingdom
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsItaly
-
Danone ResearchCompletedMild Hypercholesterolemic SubjectsGermany
-
Danone JapanCompletedNormal and Mild Hypercholesterolemic SubjectsJapan
-
Guangzhou Manjing biomedicine technology co., ltdNot yet recruitingHeart Failure With Mildly Reduced Ejection Fraction
-
National Taiwan Normal UniversityTerminatedMildly Frail | Fragile and More VulnerableTaiwan
-
Unilever R&DCompletedHealthy | Mildly Elevated Cholesterol LevelsSweden
-
University Medical Center GroningenOnze Lieve Vrouwe Gasthuis; Frisius Medisch CentrumNot yet recruitingHeart Failure | Heart Failure and Reduced Ejection Fraction | Heart Failure and Mildly Reduced Ejection FractionNetherlands
Clinical Trials on Oats
-
Democritus University of ThraceActive, not recruitingCholesterol LevelsGreece
-
Quadram Institute BioscienceClinical Research and Trials Unit (Norfolk & Norwich University Hospital,...CompletedMetabolic SyndromeUnited Kingdom
-
McMaster UniversityRecruitingCeliac Disease | Gluten Sensitivity | Gluten Enteropathy | Gluten AllergyCanada
-
Alfred Rusescu Institute for Mother and Child CareThe National Research and Development Institute for Alimentary Bioresources...Completed
-
PepsiCo Global R&DCompletedGlycemic, Insulinemic, Subjective Appetite ResponsesCanada
-
PepsiCo Global R&DCompleted
-
Tufts UniversityAgriculture and Agri-Food CanadaCompleted
-
University of TorontoCanadian Institutes of Health Research (CIHR); Quaker Oats Centre of Excellence...Active, not recruitingCardiovascular Diseases | Coronary Heart DiseaseCanada
-
University of TurkuCompletedUnidentified Gastrointestinal Symptoms Following Gluten-free Oats ConsumptionFinland